Other
Main Filters
Other
| FCI S A S FCI 20 22 | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| S1.1000 | 0 | - | ||
| S1.1100 | 0 | - | ||
| S1.1270u | 0 | - | ||
| S1.1361 | 0 | - | ||
| S1.1371 | 0 | - | ||
| S1.1390 | 0 | - | ||
| S1.1391 | 0 | - | ||
| S1.1392 | 0 | - | ||
| S1.1400 | 0 | - | ||
| S1.1450u | 0 | - | ||
| S1.1455 | 0 | - | ||
| S1.1490u | 0 | - | ||
| S1.1495 | 0 | - | ||
| S1.1500 | 0 | - | ||
| S1.1530 | 0 | - | ||
| S1.1535 | 0 | - | ||
| S1.1540 | 0 | - | ||
| S1.1550 | 0 | - | ||
| S1.1608 | 0 | - | ||
| S1.1609 | 0 | - | ||
| S1.1610 | 0 | - | ||
| S1.1630 | 0 | - | ||
| S1.1710 | 0 | - | ||
| S1.1800u | 0 | - | ||
| S1.1810u | 0 | - | ||
| S1.1820u | 0 | - | ||
| S1.1903u | 0 | - | ||
| S1.1913u | 0 | - | ||
| S1.1943u | 0 | - | ||
| S1.1953u | 0 | - | ||
| S1.3512u | 0 | - | ||
| S1.3522u | 0 | - | ||
| S2.3122u | 0 | - | ||
| S2.3324U | 0 | - | ||
| S2.3422u | 0 | - | ||
| S2.3424u | 0 | - | ||
| S2.3522u | 0 | - | ||
| S2.3524u | 0 | - | ||
| S2.3624u | 0 | - | ||
| S2.3632u | 0 | - | ||
| S2.3642u | 0 | - | ||
| S2.3652u | 0 | - | ||
| S2.3672u | 0 | - | ||
| S2.3724u | 0 | - | ||
| S2.4002u | 0 | - | ||
| SEPTODONT SAS SPECIALITES SEPTODONT | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 01C0500 | 0 | - | ||
| THERADIAG SA | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| HM 060US-2X05 | 0 | - | ||
| HM 061US-2X05 | 0 | - | ||
| MX 506 | 0 | - | ||
| MX 507 | 0 | - | ||
83,942 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
IMMUNO-TROL
THERADIAG SA
Reagent, prepared from human serum, intended for use as an unassayed precision control for determination of the following autoantibodies: Anti-double stranded deoxyribonucleic acid – Level 2 DNA* ,Anti-ribosomal antigen Ribo ,Anti-centromere antigen CENP-B ,Anti-histidyl tRNA synthetase antigen Jo-1 ,Anti-scleroderma antigen - 70 kDA Scl-70 .
0
-
IMMUNO-TROL
THERADIAG SA
Reagent, prepared from human serum, intended for use as an unassayed precision control for determination of the following autoantibodies: Anti-double stranded deoxyribonucleic acid– Level 1 DNA* ,Anti-Sjögren’s Syndrom antigen A - 60 kDa. SS-A 60, Anti-Sjögren’s Syndrom antigen A - 52 kDa SS-A 52 ,Anti-Sjögren’s Syndrom antigen B SS-B, Anti-Smith antigen Sm ,Anti-Smith and ribonucleoproteins antigens Sm/RNP ,Anti- U1 ribonucleoproteins antigen U1RNP .
0
-
FIDIS
THERADIAG SA
Simultaneous detection kit of anti-myeloperoxidase, anti-proteinase 3 and anti-glomerular basement membrane antibodies.
0
-
FIDIS
THERADIAG SA
Simultaneous detection kit of 10 antibodies: dsDNA, SSA 60, TRIM 21 (SSA 52), SSB, Sm, SmRNP, Scl70, Jo1, CENP-B, ribosomes
0
-
RITLENG+ PVP
FCI S A S FCI 20 22
An implantable short tube intended to provide a bypass route for tear drainage from the corner of the eye into the nasal cavity, or a paranasal sinus, as treatment for pathologies of the tear drainage system in association with functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent (e.g., Lester Jones type), it is implanted after surgery to dilate or maintain a surgically-created passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer materials (e.g., silicone).
0
-
RITLENG+
FCI S A S FCI 20 22
An implantable short tube intended to provide a bypass route for tear drainage from the corner of the eye into the nasal cavity, or a paranasal sinus, as treatment for pathologies of the tear drainage system in association with functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent (e.g., Lester Jones type), it is implanted after surgery to dilate or maintain a surgically-created passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer materials (e.g., silicone).
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
LACRIJET® 40
FCI S A S FCI 20 22
A collection of devices intended to be used to maintain patency of the nasolacrimal system typically for treating/preventing pathologies of the tear drainage system (e.g., post-chemotherapy stenosis) or after dacryocystorhinostomy (DCR). It consists of a long and flexible bicanalicular or monocanalicular tube (e.g., Crawford type) inserted through the lacrimal puncta into the canaliculi, lacrimal sac, and/or nasolacrimal duct; devices to assist the intubation procedure are typically provided preassembled to the tube (e.g., cannula, probes, bougies, introducer, stylet). The tube is typically left in place long-term before removal. This is a single-use device.
0
-
LACRIJET® 35
FCI S A S FCI 20 22
A collection of devices intended to be used to maintain patency of the nasolacrimal system typically for treating/preventing pathologies of the tear drainage system (e.g., post-chemotherapy stenosis) or after dacryocystorhinostomy (DCR). It consists of a long and flexible bicanalicular or monocanalicular tube (e.g., Crawford type) inserted through the lacrimal puncta into the canaliculi, lacrimal sac, and/or nasolacrimal duct; devices to assist the intubation procedure are typically provided preassembled to the tube (e.g., cannula, probes, bougies, introducer, stylet). The tube is typically left in place long-term before removal. This is a single-use device.
0
-
LACRIJET® 30
FCI S A S FCI 20 22
A collection of devices intended to be used to maintain patency of the nasolacrimal system typically for treating/preventing pathologies of the tear drainage system (e.g., post-chemotherapy stenosis) or after dacryocystorhinostomy (DCR). It consists of a long and flexible bicanalicular or monocanalicular tube (e.g., Crawford type) inserted through the lacrimal puncta into the canaliculi, lacrimal sac, and/or nasolacrimal duct; devices to assist the intubation procedure are typically provided preassembled to the tube (e.g., cannula, probes, bougies, introducer, stylet). The tube is typically left in place long-term before removal. This is a single-use device.
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a lacrimal punctum opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a lacrimal punctum opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a lacrimal punctum opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a lacrimal punctum opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a lacrimal punctum opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a punctal opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
AUTOSTABLE BICANALICULUS INTUBATION SET II (35 MM) WITH DILATOR
FCI S A S FCI 20 22
AUTOSTABLE BICANALICULUS INTUBATION SET II (35 MM) WITH DILATOR
0
-
AUTOSTABLE BICANALICULUS INTUBATION SET II (30 MM) WITH DILATOR
FCI S A S FCI 20 22
AUTOSTABLE BICANALICULUS INTUBATION SET II (30 MM) WITH DILATOR
0
-
AUTOSTABLE BICANALICULUS INTUBATION SET II (25 MM) WITH DILATOR
FCI S A S FCI 20 22
AUTOSTABLE BICANALICULUS INTUBATION SET II (25 MM) WITH DILATOR
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
Lacrimal tube
FCI S A S FCI 20 22
A sterile, implantable, single-lumen tube intended to provide tear drainage from the front surface of the eye, typically into the nasal cavity or a paranasal sinus, as a drainage treatment for lacrimal canalicular pathologies in functional or obstructive epiphora; it may also be intended to facilitate saline solution irrigation to a paranasal sinus (e.g., ethmoid sinus) to manage chronic rhinosinusitis. Also referred to as a lacrimal stent, the device may be implanted after surgery to dilate or create a surgical passage [e.g., dacryocystostomy/dacryocystorhinostomy (DCR)], and is made of glass or synthetic polymer material(s) [e.g., silicone].
0
-
BIKA BICANALICULAR INTUBATION SET J.A. BERNARD, M.D.
FCI S A S FCI 20 22
BIKA BICANALICULAR INTUBATION SET J.A. BERNARD, M.D.
0
-
Lacrimal punctum plug
FCI S A S FCI 20 22
A sterile device inserted into a lacrimal punctum opening to prevent tear outflow in dry eye patients. This is a single-use device.
0
-
LACRIJET® 50
FCI S A S FCI 20 22
A collection of devices intended to be used to maintain patency of the nasolacrimal system typically for treating/preventing pathologies of the tear drainage system (e.g., post-chemotherapy stenosis) or after dacryocystorhinostomy (DCR). It consists of a long and flexible bicanalicular or monocanalicular tube (e.g., Crawford type) inserted through the lacrimal puncta into the canaliculi, lacrimal sac, and/or nasolacrimal duct; devices to assist the intubation procedure are typically provided preassembled to the tube (e.g., cannula, probes, bougies, introducer, stylet). The tube is typically left in place long-term before removal. This is a single-use device.
